| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Cabaletta Bio Inc (NASDAQ: CABA)
CABA Technical Analysis
4
| As on 31st Oct 2025 CABA STOCK Price closed @ 3.61 and we RECOMMEND Sell for LONG-TERM with Stoploss of 4.53 & Strong Sell for SHORT-TERM with Stoploss of 9.03 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CABASTOCK Price
| Open | 2.61 | Change | Price | % |
| High | 3.67 | 1 Day | 1.14 | 46.15 |
| Low | 2.56 | 1 Week | 1.16 | 47.35 |
| Close | 3.61 | 1 Month | 1.42 | 64.84 |
| Volume | 35743905 | 1 Year | -9.01 | -71.39 |
| 52 Week High 12.88 | 52 Week Low 1.04 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| WBA | 11.98 | 0.50% |
| NVDA | 202.49 | -0.20% |
| AMZN | 244.22 | 9.58% |
| OPEN | 7.77 | 5.86% |
| LMDX | 0.02 | 0.00% |
| ONDS | 6.44 | 2.38% |
| AKTS | 0.04 | 0.00% |
| BYND | 1.66 | 0.61% |
| PLUG | 2.69 | 1.51% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| CABA Daily Charts |
CABA Intraday Charts |
Whats New @ Bazaartrend |
CABA Free Analysis |
|
|
CABA Important Levels Intraday
| RESISTANCE | 5.75 |
| RESISTANCE | 5.06 |
| RESISTANCE | 4.64 |
| RESISTANCE | 4.21 |
| SUPPORT | 3.01 |
| SUPPORT | 2.58 |
| SUPPORT | 2.16 |
| SUPPORT | 1.47 |
CABA Forecast November 2025
| 4th UP Forecast | 16.33 |
| 3rd UP Forecast | 12.25 |
| 2nd UP Forecast | 9.73 |
| 1st UP Forecast | 7.21 |
| 1st DOWN Forecast | 0.01 |
| 2nd DOWN Forecast | -2.51 |
| 3rd DOWN Forecast | -5.03 |
| 4th DOWN Forecast | -9.11 |
CABA Weekly Forecast
| 4th UP Forecast | 7.79 |
| 3rd UP Forecast | 6.45 |
| 2nd UP Forecast | 5.62 |
| 1st UP Forecast | 4.79 |
| 1st DOWN Forecast | 2.43 |
| 2nd DOWN Forecast | 1.60 |
| 3rd DOWN Forecast | 0.77 |
| 4th DOWN Forecast | -0.57 |
CABA Forecast2025
| 4th UP Forecast | 27.72 |
| 3rd UP Forecast | 19.99 |
| 2nd UP Forecast | 15.21 |
| 1st UP Forecast | 10.43 |
| 1st DOWN Forecast | -3.21 |
| 2nd DOWN Forecast | -7.99 |
| 3rd DOWN Forecast | -12.77 |
| 4th DOWN Forecast | -20.5 |
Cabaletta Bio Inc ( NASDAQ USA Symbol : CABA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CABA Business Profile
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce disease-causing autoantibodies or pathogenic B cells. The company's lead product candidate is DSG3-CAART, which is in Phase I clinical trial for the treatment of mucosal pemphigus vulgaris, an autoimmune blistering skin disease, and Hemophilia A with Factor VIII alloantibodies. Its product candidate pipeline also includes MuSK-CAART, a preclinical stage product to treat a subset of patients with myasthenia gravis; FVIII-CAART, a discovery stage product to treat a subset of patients with Hemophilia A; and DSG3/1-CAART, a discovery stage product for the treatment of mucocutaneous pemphigus vulgaris. Cabaletta Bio, Inc. has a collaboration with the University of Pennsylvania; and research agreement with The Regents of the University of California. The company was formerly known as Tycho Therapeutics, Inc. and changed its name to Cabaletta Bio, Inc. in August 2018. Cabaletta Bio, Inc. was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania. Address: 2929 Arch Street, Philadelphia, PA, United States, 19104
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service